Results 191 to 200 of about 17,658 (223)

Gemcitabine and nab-paclitaxel induced interstitial pneumonia

Diagnostic and Interventional Imaging, 2021
Claire Sabat, Claire Ginestet, Guillaume Chassagnon   +2 more
openaire   +2 more sources

Perioperative or Only Adjuvant Gemcitabine Plus Nab-Paclitaxel for Resectable Pancreatic Cancer (NEONAX)—A Randomized Phase II Trial of the AIO Pancreatic Cancer Group

Annals of Oncology, 2023
Manfred P Lutz, L Perkhofer, Ludger Staib   +2 more
exaly  

First-Line Atezolizumab Plus Nab-Paclitaxel for Unresectable, Locally Advanced, or Metastatic Triple-Negative Breast Cancer: IMpassion130 Final Overall Survival Analysis

Annals of Oncology, 2021
Leisha A Emens, V Henschel, H S Rugo
exaly  

Nab-paclitaxel

2020
openaire   +1 more source

Reminder that paclitaxel and nab-paclitaxel not interchangeable

Reactions Weekly, 2022
openaire   +1 more source

Gemcitabine and nab-paclitaxel drug interaction?

Reactions Weekly, 2022
openaire   +1 more source

Patient-Reported Outcomes From the Phase III IMpassion130 Trial of Atezolizumab Plus Nab-Paclitaxel in Metastatic Triple-Negative Breast Cancer

Annals of Oncology, 2020
V Henschel, H S Rugo, E P Winer
exaly  

Pembrolizumab and Nab-Paclitaxel as Salvage Therapy for Platinum-Treated, Locally Advanced or Metastatic Urothelial Carcinoma: Interim Results of the Open-Label, Single-Arm, Phase II PEANUT Study

Annals of Oncology, 2020
Laura Marandino, M Bandini, J S Ross
exaly  

nab-Paclitaxel plus Gemcitabin

best practice onkologie, 2012
openaire   +1 more source

Phase II Trial of Weekly Nab (Nanoparticle Albumin-Bound)-Paclitaxel (Nab-Paclitaxel) (Abraxane®) in Combination With Gemcitabine in Patients With Metastatic Breast Cancer (N0531)

Annals of Oncology, 2009
B R Laplant, V Roy
exaly